AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo

AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo

Submitted by admin on July 5, 2022 - 11:57am
Source: 
Pharmaforum
News Tags: 
AstraZeneca
TeneoTwo
M&A
hematologic cancers
Headline: 
AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo
snippet: 

AstraZeneca has signed a deal to buy US biotech TeneoTwo in a deal worth up to $1.27 billion that will boost its position therapies for hematological cancers.

Do Not Allow Advertisers to Use My Personal information